Fibrinogen Assays for Cardiovascular Risk Assessment
Open Access
- 1 May 2010
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 56 (5), 693-695
- https://doi.org/10.1373/clinchem.2010.145342
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- γ′ Fibrinogen: Evaluation of a New Assay for Study of Associations with Cardiovascular DiseaseClinical Chemistry, 2010
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2009
- Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort StudyBritish Journal of Haematology, 2009
- Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)Journal of Thrombosis and Haemostasis, 2009
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic ReviewPLoS Medicine, 2008
- SSC International Collaborative Study to establish the first high fibrinogen plasma reference material for use with different fibrinogen assay techniquesJournal of Thrombosis and Haemostasis, 2006
- Plasma fibrinogenAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2004
- Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarctionJournal of Thrombosis and Haemostasis, 2003
- Comparison of plasma fibrinogen by Clauss, prothrombin time-derived, and immunonephelometric assays in a general populationBlood Coagulation & Fibrinolysis, 2003
- Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart diseasePublished by Oxford University Press (OUP) ,2000